Horm Metab Res 2005; 37(11): 657-661
DOI: 10.1055/s-2005-870574
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

Endothelial Na+-D-glucose Cotransporter: No Role in Insulin-mediated Glucose Uptake

C.  M.  Kolka1 , S.  Rattigan1 , S.  M.  Richards1 , E.  J.  Barrett2 , M.  G.  Clark1
  • 1Dept of Biochemistry, Medical School, University of Tasmania, Hobart, Australia
  • 2University of Virginia Health Sciences Center, Charlottesville, VA, USA
Further Information

Publication History

Received 1 February 2005

Accepted after revision 17 May 2005

Publication Date:
25 November 2005 (online)

Zoom Image

Abstract

A recent report indicates that the Na+-D-glucose cotransporter SGLT1 is present in capillaries of skeletal muscle and is required for insulin-mediated glucose uptake in myocytes. This result is based on the complete inhibition of insulin-mediated muscle glucose uptake by phlorizin, an inhibitor of SGLT1. Using the pump-perfused rat hind limb, we measured glucose uptake, lactate efflux, and radioactive 2-deoxyglucose uptake into individual muscles with saline (control), phlorizin, insulin, and insulin plus phlorizin, as well as with saline and insulin using normal and low Na+ perfusion buffer. Insulin-mediated glucose uptake was not inhibited after correction for phlorizin interference in the glucose assay. Lactate efflux and 2-deoxyglucose uptake by individual muscles were unaffected by phlorizin. Low Na+ buffer did not affect insulin-mediated glucose uptake, lactate efflux, or 2-deoxyglucose uptake. We conclude that endothelial SGLT1 exerts no barrier for glucose delivery to myocytes.

Crossref Cited-by logo
Article Citations